The Changing Epidemiology of Viral Hepatitis in a Post-Soviet Country—The Case of Kyrgyzstan

• Published in: Pathogens (Basel) Vol. 12; no. 8; p. 989
• Main Authors: Akmatov, Manas K, Beisheeva, Nurgul J, Nurmatov, Asylbek Z, Gulsunai, Sattarova J, Saikal, Kylychbekova N, Derkenbaeva, Aisuluu A, Abdrahmanova, Zamira O, Prokein, Jana, Klopp, Norman, Illig, Thomas, Kasymov, Omor T, Nurmatov, Zuridin S, Pessler, Frank
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 28.07.2023; MDPI
• Subjects: Age groups; Asthma; Blood & organ donations; Confidence intervals; Cross-sectional studies; Demographic aspects; Developed countries; Developing countries; Diabetes; endemicity pattern; Epidemiology; Estimates; Ethnicity; Gender differences; Heart attacks; Hepatitis; Hepatitis A; Hepatitis B; Hepatitis B surface antigen; hepatitis C; hepatitis D; Hepatitis delta virus; hepatitis E; Hepatitis, Viral; Infections; LDCs; Males; Population; Population studies; Public health; Questionnaires; Risk factors; Seroepidemiology; Serology; Sociodemographics; Statistics; Teenagers; Kyrgyzstan; Central Asia; United States > US; Russia
• ISSN: 2076-0817; 2076-0817
• DOI: 10.3390/pathogens12080989

Historically, viral hepatitis has been a considerable public health problem in Central Asian countries, which may have worsened after the dissolution of the Soviet Union. However, up-to-date seroepidemiological studies are lacking. The aim of the present study was, therefore, to provide current estimates of the seroprevalence of viral hepatitis in Kyrgyzstan, one of the economically least developed countries in the region. We conducted a population-based cross-sectional study in 2018 in the capital of Kyrgyzstan, Bishkek (n = 1075). Participants, children and adults, were recruited from an outpatient clinic. The data were collected during face-to-face interviews. A blood sample (6 mL) was collected from each participant and tested with ELISA for the presence of serological markers for five viral hepatitides (A, B, C, D, and E). Post-stratification weighing was performed to obtain nationally representative findings. The overwhelming majority of the study participants were positive for anti-HAV (estimated seroprevalence, 75.3%; 95% confidence interval, 72.5–77.9%). The weighted seroprevalence estimates of HBsAg, anti-HCV, and anti-HDV were 2.2% (1.5–3.3%), 3.8% (2.8–5.1%), and 0.40% (0.15–1.01%), respectively. Anti-HEV seropositivity was 3.3% (2.4–4.5%). Of the 33 HBsAg-positive participants, five (15%) were anti-HDV-positive. Our study confirms that Kyrgyzstan remains a highly endemic country for hepatitis virus A and C infections. However, seroprevalences of HBV and HDV were lower than previously reported, and based on these data, the country could potentially be reclassified from high to (lower) intermediate endemicity. The observed anti-HEV seroprevalence resembles the low endemicity pattern characteristic of high-income countries.